Detalhe da pesquisa
1.
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.
Cancer
; 129(1): 71-81, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309837
2.
Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
Eur Radiol
; 33(8): 5779-5791, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894753
3.
CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Radiology
; 301(3): 610-622, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491129
4.
Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma.
Invest New Drugs
; 39(3): 821-828, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405090
5.
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib.
Clin Cancer Res
; 30(4): 687-694, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078898
6.
ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
J Natl Cancer Inst
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710487
7.
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.
Clin Genitourin Cancer
; 22(3): 102080, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653037
8.
Use of molecular biomarkers to inform adjuvant therapy for colon cancer.
Oncology (Williston Park)
; 27(8): 746-54, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24133820
9.
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.
Cancer Res Commun
; 3(12): 2572-2584, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115208
10.
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
Nat Med
; 29(6): 1400-1411, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277454
11.
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors.
Clin Cancer Res
; 28(5): 882-892, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844977
12.
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 5(2): e2149040, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179586
13.
A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis.
AME Case Rep
; 5: 14, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912803
14.
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer.
J Immunother Cancer
; 8(1)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32114502
15.
A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors.
Cancer Chemother Pharmacol
; 83(6): 1025-1035, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30895346
16.
Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.
Cancer Res Commun
; 4(3): 785, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477691
17.
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors.
Mol Endocrinol
; 21(10): 2361-77, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17595321
18.
Clinical Insights Into the Biology and Treatment of Pancreatic Cancer.
J Oncol Pract
; 12(1): 17-23, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26759461